Christence Stubbe Teglbjærg

A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density

Eric Orwoll, Christence Stubbe Teglbjærg, Bente Langdahl et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 224 citations · Full text

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

Bente Langdahl, Christence Stubbe Teglbjærg, Pei‐Ran Ho et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 129 citations · Full text

Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study

Michael A. Bolognese, Christence Stubbe Teglbjærg, José Zanchetta et al. · Journal of Clinical Densitometry · 2012 · 62 citations

Molecular Neuroscience, Neurobiology Of Disease, Freedom Study +9

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis

Kim Henriksen, J.R. Andersen, B.J. Riis et al. · Bone · 2012 · 53 citations

Pharmacokinetic Profile, Medicine, Parathyroid Hormone +9

Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix

Ulla Hørding, Christence Stubbe Teglbjærg, Jakob Visfeldt et al. · Gynecologic Oncology · 1992 · 32 citations

Cervical Cancer, Human Papillomavirus Vaccines, Pathology +10